Literature DB >> 22837967

Spinal Cord Atrophy and Early Motor Recovery following Transverse Myelitis in Pediatric Patients.

Jung Yoon Kim1, Sang Jun Kim, Moon Suk Bang.   

Abstract

OBJECTIVE: To compare the motor recovery following transverse myelitis in pediatric patients with and without spinal cord atrophy.
METHOD: From January 1995 through December 2009, twenty children (8 boys and 12 girls with an onset at 5.7±3.8 years) that were diagnosed with transverse myelitis at a Children's Hospital in Korea, and undertaken an initial and follow-up spine magnetic resonance image (MRI) were included. Medical records and spine MRI scans were reviewed retrospectively. An initial MRI was taken 5.1±8.7 days after the onset. The interval between an initial and follow-up MRIs was 33.4±23.0 days. The motor recovery differences between subjects with and without spinal cord atrophy on follow-up MRIs were determined. Motor recovery was defined as the elevation of one or more grades of manual muscle tests of the Medical Research Council.
RESULTS: Eight patients had developed spinal cord atrophies and 12 patients had not. Of the 8 patients with spinal cord atrophy, 7 showed no motor improvement. Among the 12 patients without atrophy, 11 had motor improvement. Spinal cord atrophy on follow-up MRIs were related to the risk of no motor improvement (odds ratio=77.0, 95% confidence interval [4.114-1441.049], p-value=0.001).
CONCLUSION: Children with transverse myelitis who had developed spinal cord atrophy on follow-up MRIs had poor motor recovery than those who had not. The appearance of spinal cord atrophy on follow-up MRI could be an indicator of poor prognosis in pediatric transverse myelitis.

Entities:  

Keywords:  Motor recovery; Pediatrics; Spinal cord atrophy; Transverse myelitis

Year:  2012        PMID: 22837967      PMCID: PMC3400871          DOI: 10.5535/arm.2012.36.3.328

Source DB:  PubMed          Journal:  Ann Rehabil Med        ISSN: 2234-0645


  14 in total

1.  14-3-3 protein in the cerebrospinal fluid of patients with acute transverse myelitis.

Authors:  D N Irani; D A Kerr
Journal:  Lancet       Date:  2000-03-11       Impact factor: 79.321

2.  Progression of spinal cord atrophy by traumatic or inflammatory myelopathy in the pediatric patients: case series.

Authors:  M S Bang; S J Kim
Journal:  Spinal Cord       Date:  2009-01-27       Impact factor: 2.772

Review 3.  Proposed diagnostic criteria and nosology of acute transverse myelitis.

Authors: 
Journal:  Neurology       Date:  2002-08-27       Impact factor: 9.910

4.  Transverse myelitis. Retrospective analysis of 33 cases, with differentiation of cases associated with multiple sclerosis and parainfectious events.

Authors:  D R Jeffery; R N Mandler; L E Davis
Journal:  Arch Neurol       Date:  1993-05

5.  Acute transverse myelitis: incidence and etiologic considerations.

Authors:  M Berman; S Feldman; M Alter; N Zilber; E Kahana
Journal:  Neurology       Date:  1981-08       Impact factor: 9.910

6.  Acute transverse myelitis in children: clinical course and prognostic factors.

Authors:  Pierre Defresne; Henri Hollenberg; Béatrice Husson; Brahim Tabarki; Pierre Landrieu; Gilbert Huault; Marc Tardieu; Guillaume Sébire
Journal:  J Child Neurol       Date:  2003-06       Impact factor: 1.987

Review 7.  Acute transverse myelitis in childhood: nine cases and review of the literature.

Authors:  M Knebusch; H M Strassburg; K Reiners
Journal:  Dev Med Child Neurol       Date:  1998-09       Impact factor: 5.449

8.  Demonstration of acute post-viral myelitis with magnetic resonance imaging.

Authors:  G Awerbuch; W M Feinberg; P Ferry; N N Komar; J Clements
Journal:  Pediatr Neurol       Date:  1987 Nov-Dec       Impact factor: 3.372

9.  Acute transverse myelopathy in childhood.

Authors:  K Dunne; I J Hopkins; L K Shield
Journal:  Dev Med Child Neurol       Date:  1986-04       Impact factor: 5.449

10.  Investigating cervical spinal cord structure using axial diffusion tensor imaging.

Authors:  Claudia A M Wheeler-Kingshott; Simon J Hickman; Geoffrey J M Parker; Olga Ciccarelli; Mark R Symms; David H Miller; Gareth J Barker
Journal:  Neuroimage       Date:  2002-05       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.